Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Cambau, E; Bonnafous, P; Perani, E; Sougakoff, W; Ji, BH; Jarlier, V
   Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy
   CLINICAL INFECTIOUS DISEASES
   
   E. Cambau et al., "Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy", CLIN INF D, 34(1), 2002, pp. 39-45
2. Nawrocki, A; Fey, SJ; Goffeau, A; Roepstorff, P; Larsen, PM
   The effects of transcription regulating genes PDR1, pdr1-3 and PDR3 in pleiotropic drug resistance
   PROTEOMICS
   
   A. Nawrocki et al., "The effects of transcription regulating genes PDR1, pdr1-3 and PDR3 in pleiotropic drug resistance", PROTEOMICS, 1(8), 2001, pp. 1022-1032
3. Hutter, G; Sinha, P
   Proteomics for studying cancer cells and the development of chemoresistance
   PROTEOMICS
   
   G. Hutter e P. Sinha, "Proteomics for studying cancer cells and the development of chemoresistance", PROTEOMICS, 1(10), 2001, pp. 1233-1248
4. Iwalokun, BA; Gbenle, GO; Smith, SI; Ogunledun, A; Akinsinde, KA; Omonigbehin, EA
   Epidemiology of shigellosis in Lagos, Nigeria: Trends in antimicrobial resistance
   JOURNAL OF HEALTH POPULATION AND NUTRITION
   
   B.A. Iwalokun et al., "Epidemiology of shigellosis in Lagos, Nigeria: Trends in antimicrobial resistance", J HEALTH PO, 19(3), 2001, pp. 183-190
5. Rahman, M; Islam, R; Ahmed, D; Sack, RB
   Emergence of multidrug-resistant Salmonella Gloucester and Salmonella Typhimurium in Bangladesh
   JOURNAL OF HEALTH POPULATION AND NUTRITION
   
   M. Rahman et al., "Emergence of multidrug-resistant Salmonella Gloucester and Salmonella Typhimurium in Bangladesh", J HEALTH PO, 19(3), 2001, pp. 191-198
6. Hofer, E; Reis, EMF; Quintaes, BR; Rodrigues, DP; Feitosa, IS; Angelo, MRF; Ribeiro, LHFF
   Vibrio cholerae resistant to 2,4-diamino-6,7-diisopropylpteridine (O/129) isolated from patients with Enteritis in Ceara, Brazil
   JOURNAL OF HEALTH POPULATION AND NUTRITION
   
   E. Hofer et al., "Vibrio cholerae resistant to 2,4-diamino-6,7-diisopropylpteridine (O/129) isolated from patients with Enteritis in Ceara, Brazil", J HEALTH PO, 19(1), 2001, pp. 39-42
7. Gately, S; Kerbel, R
   Antiangiogenic scheduling of lower dose cancer chemotherapy
   CANCER JOURNAL
   
   S. Gately e R. Kerbel, "Antiangiogenic scheduling of lower dose cancer chemotherapy", CANCER J, 7(5), 2001, pp. 427-436
8. Anderson, KC
   Novel biologically based therapies for myeloma
   CANCER JOURNAL
   
   K.C. Anderson, "Novel biologically based therapies for myeloma", CANCER J, 7, 2001, pp. S19-S23
9. Groschel, B; Hover, G; Doerr, HW; Cinatl, J
   Zidovudine (AZT) resistance in H9 cells due to decreased TK expression is associated with hypermethylation of TK gene
   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
   
   B. Groschel et al., "Zidovudine (AZT) resistance in H9 cells due to decreased TK expression is associated with hypermethylation of TK gene", NUCLEOS NUC, 20(4-7), 2001, pp. 487-492
10. Masquelier, B; Neau, D; Chene, G; Larbere, J; Birac, V; Ragnaud, JM; Fleury, HJA
    Mechanism of virologic failure after substitution of a protease inhibitor by nevirapine in patients with suppressed plasma HIV-1 RNA
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    B. Masquelier et al., "Mechanism of virologic failure after substitution of a protease inhibitor by nevirapine in patients with suppressed plasma HIV-1 RNA", J ACQ IMM D, 28(4), 2001, pp. 309-312
11. Kyriakides, TC; Heimer, RR
    Development and application of a genotypic AZT resistance assay - Quantitative assessment of the resistance profile of clinical samples and the relative predictive ability of a resistance index
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    T.C. Kyriakides e R.R. Heimer, "Development and application of a genotypic AZT resistance assay - Quantitative assessment of the resistance profile of clinical samples and the relative predictive ability of a resistance index", J ACQ IMM D, 28(3), 2001, pp. 211-220
12. Beinker, NK; Mayers, DL; Lange, CG; Valdez, H; Sitkins, J; Lemonnier, L; Chowdhry, TK; Lederman, MM
    Genotypic drug resistance and cause of death in HIV-infected persons who died in 1999
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    N.K. Beinker et al., "Genotypic drug resistance and cause of death in HIV-infected persons who died in 1999", J ACQ IMM D, 28(3), 2001, pp. 250-253
13. Roberts, DE; Ribeiro, RM
    Comparison of different treatment regimens for the emergence of new resistance under therapy
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    D.E. Roberts e R.M. Ribeiro, "Comparison of different treatment regimens for the emergence of new resistance under therapy", J ACQ IMM D, 27(4), 2001, pp. 331-335
14. Shulman, NS; Machekano, RA; Shafer, RW; Winters, MA; Zolopa, AR; Liou, SH; Hughes, M; Katzenstein, DA
    Genotypic correlates of a virologic response to stavudine after zidovudinemonotherapy
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    N.S. Shulman et al., "Genotypic correlates of a virologic response to stavudine after zidovudinemonotherapy", J ACQ IMM D, 27(4), 2001, pp. 377-380
15. Masquelier, B; Chaix, ML; Burgard, M; Lechenadec, J; Doussin, A; Simon, F; Cottalorda, J; Izopet, J; Tamalet, C; Douard, D; Fleury, H; Mayaux, MJ; Blanche, S; Rouzioux, C
    Zidovudine genotypic resistance in HIV-1-infected newborns in the French Perinatal Cohort
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    B. Masquelier et al., "Zidovudine genotypic resistance in HIV-1-infected newborns in the French Perinatal Cohort", J ACQ IMM D, 27(2), 2001, pp. 99-104
16. Weidle, PJ; Kityo, CM; Mugyenyi, P; Downing, R; Kebba, A; Pieniazek, D; Respess, R; Hertogs, K; De Vroey, V; Dehertogh, P; Bloor, S; Larder, B; Lackritz, E
    Resistance to antiretroviral therapy among patients in Uganda
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    P.J. Weidle et al., "Resistance to antiretroviral therapy among patients in Uganda", J ACQ IMM D, 26(5), 2001, pp. 495-500
17. Adje, C; Cheingsong, R; Roels, TH; Maurice, C; Djomand, G; Verbiest, W; Hertogs, K; Larder, B; Monga, B; Peeters, M; Eholie, S; Bissagene, E; Coulibaly, M; Respess, R; Wiktor, SZ; Chorba, T; Nkengasong, JN
    High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote d'Ivoire
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    C. Adje et al., "High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote d'Ivoire", J ACQ IMM D, 26(5), 2001, pp. 501-506
18. Duwe, S; Brunn, M; Altmann, D; Hamouda, O; Schmidt, B; Walter, H; Pauli, G; Kucherer, C
    Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    S. Duwe et al., "Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study", J ACQ IMM D, 26(3), 2001, pp. 266-273
19. Tchetgen, E; Kaplan, EH; Friedland, GH
    Public health consequences of screening patients for adherence to highly active antiretroviral therapy
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    E. Tchetgen et al., "Public health consequences of screening patients for adherence to highly active antiretroviral therapy", J ACQ IMM D, 26(2), 2001, pp. 118-129
20. Briones, C; Perez-Olmeda, M; Rodriguez, C; del Romero, J; Hertogs, K; Soriano, V
    Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    C. Briones et al., "Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid", J ACQ IMM D, 26(2), 2001, pp. 145-150
21. Demeter, L; Haubrich, R
    Phenotypic and genotypic resistance assays: Methodology, reliability, and interpretations
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    L. Demeter e R. Haubrich, "Phenotypic and genotypic resistance assays: Methodology, reliability, and interpretations", J ACQ IMM D, 26, 2001, pp. S3-S9
22. Loveday, C
    Nucleoside reverse transcriptase inhibitor resistance
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    C. Loveday, "Nucleoside reverse transcriptase inhibitor resistance", J ACQ IMM D, 26, 2001, pp. S10-S24
23. Miller, V
    Resistance to protease inhibitors
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    V. Miller, "Resistance to protease inhibitors", J ACQ IMM D, 26, 2001, pp. S34-S50
24. Haubrich, R; Demeter, L
    Clinical utility of resistance testing: Retrospective and prospective datasupporting use and current recommendations
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    
    R. Haubrich e L. Demeter, "Clinical utility of resistance testing: Retrospective and prospective datasupporting use and current recommendations", J ACQ IMM D, 26, 2001, pp. S51-S59
25. Chalmers, D; Ferrand, C; Apperley, JF; Melo, JV; Ebeling, S; Newton, I; Duperrier, A; Hagenbeek, A; Garrett, E; Tiberghien, P; Garin, M
    Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene
    MOLECULAR THERAPY
    
    D. Chalmers et al., "Elimination of the truncated message from the herpes simplex virus thymidine kinase suicide gene", MOL THER, 4(2), 2001, pp. 146-148
26. Sawai, N; Zhou, S; Vanin, EF; Houghton, P; Brent, TP; Sorrentino, BP
    Protection and in vivo selection of hematopoietic stem cells using temozolomide, O-6-benzylguanine, and an alkyltransferase-expressing retroviral vector
    MOLECULAR THERAPY
    
    N. Sawai et al., "Protection and in vivo selection of hematopoietic stem cells using temozolomide, O-6-benzylguanine, and an alkyltransferase-expressing retroviral vector", MOL THER, 3(1), 2001, pp. 78-87
27. Treon, SP; Mitsiades, C; Mitsiades, N; Young, G; Doss, D; Schlossman, R; Anderson, KC
    Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies
    JOURNAL OF IMMUNOTHERAPY
    
    S.P. Treon et al., "Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies", J IMMUNOTH, 24(3), 2001, pp. 263-271
28. Regueiro-Ren, A; Borzilleri, RM; Zheng, XP; Kim, SH; Johnson, JA; Fairchild, CR; Lee, FYF; Long, BH; Vite, GD
    Synthesis and biological activity of novel epothilone aziridines
    ORGANIC LETTERS
    
    A. Regueiro-Ren et al., "Synthesis and biological activity of novel epothilone aziridines", ORG LETT, 3(17), 2001, pp. 2693-2696
29. Fingleton, B; Vargo-Gogola, T; Crawford, HC; Matrisian, LM
    Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis
    NEOPLASIA
    
    B. Fingleton et al., "Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis", NEOPLASIA, 3(6), 2001, pp. 459-468
30. Raghunand, N; Mahoney, B; van Sluis, R; Baggett, B; Gillies, RJ
    Acute metabolic alkalosis enhances response of C3H mouse mammary tumors tothe weak base mitoxantrone
    NEOPLASIA
    
    N. Raghunand et al., "Acute metabolic alkalosis enhances response of C3H mouse mammary tumors tothe weak base mitoxantrone", NEOPLASIA, 3(3), 2001, pp. 227-235
31. Sonneveld, P; List, AF
    Chemotherapy resistance in acute myeloid leukaemia
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    
    P. Sonneveld e A.F. List, "Chemotherapy resistance in acute myeloid leukaemia", BEST P R C, 14(1), 2001, pp. 211-233
32. Diaz, N; Suarez, D; Sordo, TL; Merz, KM
    Acylation of class a beta-lactamases by penicillins: A theoretical examination of the role of serine 130 and the beta-lactam carboxylate group
    JOURNAL OF PHYSICAL CHEMISTRY B
    
    N. Diaz et al., "Acylation of class a beta-lactamases by penicillins: A theoretical examination of the role of serine 130 and the beta-lactam carboxylate group", J PHYS CH B, 105(45), 2001, pp. 11302-11313
33. Awadalla, P; Walliker, D; Babiker, H; Mackinnon, M
    The question of Plasmodium faliciparum population structure
    TRENDS IN PARASITOLOGY
    
    P. Awadalla et al., "The question of Plasmodium faliciparum population structure", TRENDS PARA, 17(8), 2001, pp. 351-353
34. Sibley, CH; Hyde, JE; Sims, PFG; Plowe, CV; Kublin, JG; Mberu, EK; Cowman, AF; Winstanley, PA; Watkins, WM; Nzila, AM
    Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?
    TRENDS IN PARASITOLOGY
    
    C.H. Sibley et al., "Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?", TRENDS PARA, 17(12), 2001, pp. 582-588
35. Nawrocki, A; Fey, SJ; Larsen, PM; Goffeau, A; Roepstorff, P
    The effects of transcription regulating genes PDR1, pdr1-3 and PDR3 in pleiotropic drug resistance
    EUROPEAN JOURNAL OF MASS SPECTROMETRY
    
    A. Nawrocki et al., "The effects of transcription regulating genes PDR1, pdr1-3 and PDR3 in pleiotropic drug resistance", EUR J MASS, 7(2), 2001, pp. 195-205
36. Somoskovi, A; Parsons, LM; Salfinger, M
    The molecular basis of resistance to isoniazid, rifampin, and pyrazinamidein Mycobacterium tuberculosis
    RESPIRATORY RESEARCH
    
    A. Somoskovi et al., "The molecular basis of resistance to isoniazid, rifampin, and pyrazinamidein Mycobacterium tuberculosis", RESPIR RES, 2(3), 2001, pp. 164-168
37. Makin, G; Dive, C
    Modulating sensitivity to drug-induced apoptosis: the future for chemotherapy?
    BREAST CANCER RESEARCH
    
    G. Makin e C. Dive, "Modulating sensitivity to drug-induced apoptosis: the future for chemotherapy?", BREAST CA R, 3(3), 2001, pp. 150-153
38. Hayes, MC; Birch, BR; Cooper, AJ; Primrose, JN
    Cellular resistance to mitomycin C is associated with overexpression of MDR-1 in a urothelial cancer cell line (MGH-U1)
    BJU INTERNATIONAL
    
    M.C. Hayes et al., "Cellular resistance to mitomycin C is associated with overexpression of MDR-1 in a urothelial cancer cell line (MGH-U1)", BJU INT, 87(3), 2001, pp. 245-250
39. Lan, SH; Chang, WN; Lu, CH; Lui, CC; Chang, HW
    Cerebral infarction in chronic meningitis: a comparison of tuberculous meningitis and cryptococcal meningitis
    QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS
    
    S.H. Lan et al., "Cerebral infarction in chronic meningitis: a comparison of tuberculous meningitis and cryptococcal meningitis", QJM-MON J A, 94(5), 2001, pp. 247-253
40. Staib, P; Wirsching, S; Strauss, A; Morschhauser, J
    Gene regulation and host adaptation mechanisms in Candida albicans
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
    
    P. Staib et al., "Gene regulation and host adaptation mechanisms in Candida albicans", INT J MED M, 291(2), 2001, pp. 183-188
41. Pancaldi, S; Bonora, A; Baldisserotto, C; Gualandri, R; Neri, LM; Fasulo, MP
    Deregulation of light-induced plastidogenesis in etiolated Euglena gracilis klebs treated with DNA hypermethylating 3 '-azido-3 '-deoxythymidine
    PLANT BIOLOGY
    
    S. Pancaldi et al., "Deregulation of light-induced plastidogenesis in etiolated Euglena gracilis klebs treated with DNA hypermethylating 3 '-azido-3 '-deoxythymidine", PLANT BIO, 3(5), 2001, pp. 524-535
42. Bellincampi, L; Ballerini, S; Bernardini, S; Inserra, A; Marchetti, P; Boglino, C; Donfrancesco, A; Federici, G
    Glutathione transferase P1 polymorphism in neuroblastoma studied by endonuclease restriction mapping
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    
    L. Bellincampi et al., "Glutathione transferase P1 polymorphism in neuroblastoma studied by endonuclease restriction mapping", CLIN CH L M, 39(9), 2001, pp. 830-835
43. Conrad, S; Kauffmann, HM; Ito, K; Deeley, RG; Cole, SPC; Schrenk, D
    Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution
    JOURNAL OF HUMAN GENETICS
    
    S. Conrad et al., "Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution", J HUM GENET, 46(11), 2001, pp. 656-663
44. Langer, P; Wuckelt, J; Doring, M; Gorls, H
    Double anion capture reactions of anthranilic esters with oxaldiimidoyl dichlorides - Efficient synthesis of 2,2'-biquinazoline-4,4'(3H,3'H)-diones
    EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
    
    P. Langer et al., "Double anion capture reactions of anthranilic esters with oxaldiimidoyl dichlorides - Efficient synthesis of 2,2'-biquinazoline-4,4'(3H,3'H)-diones", EUR J ORG C, (8), 2001, pp. 1503-1509
45. Ehrnsperger, C; Volknandt, W
    Major vault protein is a substrate of endogenous protein kinases in CHO and PC12 cells
    BIOLOGICAL CHEMISTRY
    
    C. Ehrnsperger e W. Volknandt, "Major vault protein is a substrate of endogenous protein kinases in CHO and PC12 cells", BIOL CHEM, 382(10), 2001, pp. 1463-1471
46. Arens, M
    Clinically relevant sequence-based genotyping of HBV, HCV, CMV, and HIV
    JOURNAL OF CLINICAL VIROLOGY
    
    M. Arens, "Clinically relevant sequence-based genotyping of HBV, HCV, CMV, and HIV", J CLIN VIRO, 22(1), 2001, pp. 11-29
47. Garcia-Lerma, JG; Heneine, W
    Resistance of human immunodeficiency virus type 1 to reverse transcriptaseand protease inhibitors: genotypic and phenotypic testing
    JOURNAL OF CLINICAL VIROLOGY
    
    J.G. Garcia-Lerma e W. Heneine, "Resistance of human immunodeficiency virus type 1 to reverse transcriptaseand protease inhibitors: genotypic and phenotypic testing", J CLIN VIRO, 21(3), 2001, pp. 197-212
48. Mutimer, D
    Hepatitis B virus infection: resistance to antiviral agents
    JOURNAL OF CLINICAL VIROLOGY
    
    D. Mutimer, "Hepatitis B virus infection: resistance to antiviral agents", J CLIN VIRO, 21(3), 2001, pp. 239-242
49. Koch, N; Tamalet, C; Tivoli, N; Fantini, J; Yahi, N
    Comparison of two commercial assays for the detection of insertion mutations of HIV-1 reverse transcriptase
    JOURNAL OF CLINICAL VIROLOGY
    
    N. Koch et al., "Comparison of two commercial assays for the detection of insertion mutations of HIV-1 reverse transcriptase", J CLIN VIRO, 21(2), 2001, pp. 153-162
50. Kartalou, M; Essigmann, JM
    Mechanisms of resistance to cisplatin
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    
    M. Kartalou e J.M. Essigmann, "Mechanisms of resistance to cisplatin", MUT RES-F M, 478(1-2), 2001, pp. 23-43
51. Cnubben, NHP; Rietjens, IMCM; Wortelboer, H; van Zanden, J; van Bladeren, PJ
    The interplay of glutathione-related processes in antioxidant defense
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
    
    N.H.P. Cnubben et al., "The interplay of glutathione-related processes in antioxidant defense", ENV TOX PH, 10(4), 2001, pp. 141-152
52. Carlton, JMR; Fidock, DA; Djimde, A; Plowe, CV; Wellems, TE
    Conservation of a novel vacuolar transporter in Plasmodium species and itscentral role in chloroquine resistance of P-falciparum
    CURRENT OPINION IN MICROBIOLOGY
    
    J.M.R. Carlton et al., "Conservation of a novel vacuolar transporter in Plasmodium species and itscentral role in chloroquine resistance of P-falciparum", CURR OPIN M, 4(4), 2001, pp. 415-420
53. Edlind, TD; Henry, KW; Metera, KA; Katiyar, SK
    Aspergillus fumigatus CYP51 sequence: potential basis for fluconazole resistance
    MEDICAL MYCOLOGY
    
    T.D. Edlind et al., "Aspergillus fumigatus CYP51 sequence: potential basis for fluconazole resistance", MED MYCOL, 39(3), 2001, pp. 299-302
54. Plettenberg, A; Albrecht, D; Lorenzen, T; Paech, V; Petersen, H; Fenner, T; Meyer, T; Arndt, R; Hertogs, K; Pauwels, R; Weitzel, T; Stoehr, A
    Resistance analyses in HIV infected patients with a history of multiple antiretroviral treatment regimens
    SEXUALLY TRANSMITTED INFECTIONS
    
    A. Plettenberg et al., "Resistance analyses in HIV infected patients with a history of multiple antiretroviral treatment regimens", SEX TRANS I, 77(6), 2001, pp. 449-452
55. Kowalski, J
    A non-parametric approach to translating gene region heterogeneity associated with phenotype into location heterogeneity
    BIOINFORMATICS
    
    J. Kowalski, "A non-parametric approach to translating gene region heterogeneity associated with phenotype into location heterogeneity", BIOINFORMAT, 17(9), 2001, pp. 775-790
56. Flowers, P
    Gay men and HIV/AIDS risk management
    HEALTH
    
    P. Flowers, "Gay men and HIV/AIDS risk management", HEALTH, 5(1), 2001, pp. 50-75
57. Liang, YS; Dai, JR; Ning, A; Yu, DB; Xu, XJ; Zhu, YC; Coles, GC
    Susceptibility of Schistosoma japonicum to praziquantel in China
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    Y.S. Liang et al., "Susceptibility of Schistosoma japonicum to praziquantel in China", TR MED I H, 6(9), 2001, pp. 707-714
58. Gibson, W
    Molecular characterization of field isolates of human pathogenic trypanosomes
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    W. Gibson, "Molecular characterization of field isolates of human pathogenic trypanosomes", TR MED I H, 6(5), 2001, pp. 401-406
59. Matovu, E; Enyaru, JCK; Legros, D; Schmid, C; Seebeck, T; Kaminsky, R
    Melarsoprol refractory T-b. gambiense from Omugo, north-western Uganda
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    E. Matovu et al., "Melarsoprol refractory T-b. gambiense from Omugo, north-western Uganda", TR MED I H, 6(5), 2001, pp. 407-411
60. Burri, C; Keiser, J
    Pharmacokinetic investigations in patients from northern Angola refractoryto melarsoprol treatment
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    C. Burri e J. Keiser, "Pharmacokinetic investigations in patients from northern Angola refractoryto melarsoprol treatment", TR MED I H, 6(5), 2001, pp. 412-420
61. von Seidlein, L; Jawara, M; Coleman, R; Doherty, T; Walraven, G; Targett, G
    Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    L. von Seidlein et al., "Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria", TR MED I H, 6(2), 2001, pp. 92-98
62. Sundar, S
    Drug resistance in Indian visceral leishmaniasis
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    S. Sundar, "Drug resistance in Indian visceral leishmaniasis", TR MED I H, 6(11), 2001, pp. 849-854
63. Gryseels, B; Mbaye, A; De Vlas, SJ; Stelma, FF; Guisse, F; Van Lieshout, L; Faye, D; Diop, M; Ly, A; Tchuem-Tchuente, LA; Engels, D; Polman, K
    Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    B. Gryseels et al., "Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence", TR MED I H, 6(11), 2001, pp. 864-873
64. Ouellette, M
    Biochemical and molecular mechanisms of drug resistance in parasites
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    M. Ouellette, "Biochemical and molecular mechanisms of drug resistance in parasites", TR MED I H, 6(11), 2001, pp. 874-882
65. Mutabingwa, TK
    Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    T.K. Mutabingwa, "Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience", TR MED I H, 6(11), 2001, pp. 891-898
66. Croft, SL
    Monitoring drug resistance in leishmaniasis
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    S.L. Croft, "Monitoring drug resistance in leishmaniasis", TR MED I H, 6(11), 2001, pp. 899-905
67. Brun, R; Schumacher, R; Schmid, C; Kunz, C; Burri, C
    The phenomenon of treatment failures in Human African Trypanosomiasis
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    R. Brun et al., "The phenomenon of treatment failures in Human African Trypanosomiasis", TR MED I H, 6(11), 2001, pp. 906-914
68. Geerts, S; Gryseels, B
    Anthelmintic resistance in human helminths: a review
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    S. Geerts e B. Gryseels, "Anthelmintic resistance in human helminths: a review", TR MED I H, 6(11), 2001, pp. 915-921
69. Olliaro, P; Taylor, WRJ; Rigal, J
    Controlling malaria: challenges and solutions
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    P. Olliaro et al., "Controlling malaria: challenges and solutions", TR MED I H, 6(11), 2001, pp. 922-927
70. Bryceson, A
    A policy for leishmaniasis with respect to the prevention and control of drug resistance
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    A. Bryceson, "A policy for leishmaniasis with respect to the prevention and control of drug resistance", TR MED I H, 6(11), 2001, pp. 928-934
71. Winstanley, P
    Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    P. Winstanley, "Chlorproguanil-dapsone (LAPDAP) for uncomplicated falciparum malaria", TR MED I H, 6(11), 2001, pp. 952-954
72. Eberl, KJ; Jelinek, T; Aida, AO; Peyerl-Hoffmann, G; Heuschkel, C; el Valy, AO; Christophel, EM
    Prevalence of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from southern Mauritania
    TROPICAL MEDICINE & INTERNATIONAL HEALTH
    
    K.J. Eberl et al., "Prevalence of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum isolates from southern Mauritania", TR MED I H, 6(10), 2001, pp. 756-760
73. Buss, N; Cammack, N
    Measuring the effectiveness of antiretroviral agents
    ANTIVIRAL THERAPY
    
    N. Buss e N. Cammack, "Measuring the effectiveness of antiretroviral agents", ANTIVIR TH, 6(1), 2001, pp. 1-7
74. Rusconi, S; Catamancio, SL; Citterio, P; Bulgheroni, E; Kurtagic, S; Galazzi, M; Croce, F; Moroni, M; Galli, M
    Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine
    ANTIVIRAL THERAPY
    
    S. Rusconi et al., "Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine", ANTIVIR TH, 6(1), 2001, pp. 41-46
75. Pillay, D
    The emergence and epidemiology of resistance in the nucleoside-experiencedHIV-infected population
    ANTIVIRAL THERAPY
    
    D. Pillay, "The emergence and epidemiology of resistance in the nucleoside-experiencedHIV-infected population", ANTIVIR TH, 6, 2001, pp. 15-24
76. Miller, V
    Interpretation of resistance assay results
    ANTIVIRAL THERAPY
    
    V. Miller, "Interpretation of resistance assay results", ANTIVIR TH, 6, 2001, pp. 1-9
77. Harries, M; Kaye, SB
    Recent advances in the treatment of epithelial ovarian cancer
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    M. Harries e S.B. Kaye, "Recent advances in the treatment of epithelial ovarian cancer", EXPERT OP I, 10(9), 2001, pp. 1715-1724
78. Mank, TG; Zaat, JOM
    Diagnostic advantages and therapeutic options for giardiasis
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    T.G. Mank e J.O.M. Zaat, "Diagnostic advantages and therapeutic options for giardiasis", EXPERT OP I, 10(8), 2001, pp. 1513-1519
79. McKeage, MJ
    Lobaplatin: a new antitumour platinum drug
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    M.J. McKeage, "Lobaplatin: a new antitumour platinum drug", EXPERT OP I, 10(1), 2001, pp. 119-128
80. Durand, R; Savel, J
    Dihydrofolate reductase inhibitors: new developments in antiparasitic chemotherapy
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    R. Durand e J. Savel, "Dihydrofolate reductase inhibitors: new developments in antiparasitic chemotherapy", EXPERT OP T, 11(8), 2001, pp. 1285-1290
81. Egan, TJ
    Quinoline antimalarials
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    T.J. Egan, "Quinoline antimalarials", EXPERT OP T, 11(2), 2001, pp. 185-209
82. Burt, ET
    Current approaches to the treatment of Candida albicans infections
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    E.T. Burt, "Current approaches to the treatment of Candida albicans infections", EXPERT OP T, 11(2), 2001, pp. 269-282
83. Tentori, L; Balduzzi, A; Portarena, I; Levati, L; Vernole, P; Gold, B; Bonmassar, E; Graziani, G
    Poly (ADP-ribose) polymerase inhibitor increases apoptosis and reduces necrosis induced by a DNA minor groove binding methyl sulfonate ester
    CELL DEATH AND DIFFERENTIATION
    
    L. Tentori et al., "Poly (ADP-ribose) polymerase inhibitor increases apoptosis and reduces necrosis induced by a DNA minor groove binding methyl sulfonate ester", CELL DEAT D, 8(8), 2001, pp. 817-828
84. Tentori, L; Portarena, I; Bonmassar, E; Graziani, G
    Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cells
    CELL DEATH AND DIFFERENTIATION
    
    L. Tentori et al., "Combined effects of adenovirus-mediated wild-type p53 transduction, temozolomide and poly (ADP-ribose) polymerase inhibitor in mismatch repair deficient and non-proliferating tumor cells", CELL DEAT D, 8(5), 2001, pp. 457-469
85. Cangelosi, GA; Palermo, CO; Bermudez, LE
    Phenotypic consequences of red-white colony type variation in Mycobacterium avium
    MICROBIOLOGY-UK
    
    G.A. Cangelosi et al., "Phenotypic consequences of red-white colony type variation in Mycobacterium avium", MICROBIO-UK, 147, 2001, pp. 527-533
86. Matovu, E; Seebeck, T; Enyaru, JCK; Kaminsky, R
    Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle
    MICROBES AND INFECTION
    
    E. Matovu et al., "Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle", MICROBES IN, 3(9), 2001, pp. 763-770
87. Rabsch, W; Tschape, H; Baumler, AJ
    Non-typhoidal salmonellosis: emerging problems
    MICROBES AND INFECTION
    
    W. Rabsch et al., "Non-typhoidal salmonellosis: emerging problems", MICROBES IN, 3(3), 2001, pp. 237-247
88. Dreno, B; Raynaud, A; Moyse, D; Habert, W; Richet, H
    Erythromycin-resistance of cutaneous bacterial flora in acne
    EUROPEAN JOURNAL OF DERMATOLOGY
    
    B. Dreno et al., "Erythromycin-resistance of cutaneous bacterial flora in acne", EUR J DERM, 11(6), 2001, pp. 549-553
89. Fanci, R; Paci, C; Pecile, P
    Isolation frequency and antimicrobial susceptibility of Pseudomonas aeruginosa bloodstream infections in neuropenic patients with acute leukemia
    JOURNAL OF CHEMOTHERAPY
    
    R. Fanci et al., "Isolation frequency and antimicrobial susceptibility of Pseudomonas aeruginosa bloodstream infections in neuropenic patients with acute leukemia", J CHEMOTHER, 13(2), 2001, pp. 213-215
90. Walsh, AC; Feulner, JA; Reilly, A
    Evidence for functionally significant polymorphism of human glutamate cysteine ligase catalytic subunit: Association with glutathione levels and drugresistance in the national cancer institute tumor cell line panel
    TOXICOLOGICAL SCIENCES
    
    A.C. Walsh et al., "Evidence for functionally significant polymorphism of human glutamate cysteine ligase catalytic subunit: Association with glutathione levels and drugresistance in the national cancer institute tumor cell line panel", TOXICOL SCI, 61(2), 2001, pp. 218-223
91. Ramachandran, C; Melnick, SJ; Escalon, E; Khatib, Z; Jhabvala, P; Fonseca, HB; Smith, S; Alamo, A; Medina, S
    Cytogenetic and molecular characterization of a congenital mesoblastic nephroma
    PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
    
    C. Ramachandran et al., "Cytogenetic and molecular characterization of a congenital mesoblastic nephroma", PEDIATR D P, 4(4), 2001, pp. 402-411
92. Jones, S; Klotman, ME
    Impact of genotypic resistance testing on physician selection of antiretroviral therapy
    JOURNAL OF HUMAN VIROLOGY
    
    S. Jones e M.E. Klotman, "Impact of genotypic resistance testing on physician selection of antiretroviral therapy", J HUMAN VIR, 4(4), 2001, pp. 214-216
93. Ross, L; Henry, K; Paar, D; Salvato, P; Shaefer, M; Fisher, R; Liao, QM; St Clair, M
    Thymidine-analog and multi-nucleoside resistance mutations are observed inboth zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens
    JOURNAL OF HUMAN VIROLOGY
    
    L. Ross et al., "Thymidine-analog and multi-nucleoside resistance mutations are observed inboth zidovudine-naive and zidovudine-experienced subjects with viremia after treatment with stavudine-containing regimens", J HUMAN VIR, 4(4), 2001, pp. 217-222
94. Su, J; Andersson, E; Horai, P; Naghavi, MH; Palm, A; Wu, YP; Eriksson, K; Jansson, M; Wigzell, H; Svennerholm, B; Vahlne, A
    The nontoxic tripeptide glycyl-prolyl-glycine amide inhibits the replication of human immunodeficiency virus type 1
    JOURNAL OF HUMAN VIROLOGY
    
    J. Su et al., "The nontoxic tripeptide glycyl-prolyl-glycine amide inhibits the replication of human immunodeficiency virus type 1", J HUMAN VIR, 4(1), 2001, pp. 1-7
95. Tugendreich, S; Perkins, E; Couto, J; Barthmaier, P; Sun, DX; Tang, S; Tulac, S; Nguyen, A; Yeh, E; Mays, A; Wallace, E; Lila, T; Shivak, D; Prichard, M; Andrejka, L; Kim, R; Melese, T
    A streamlined process to phenotypically profile heterologous cDNAs in parallel using yeast cell-based assays
    GENOME RESEARCH
    
    S. Tugendreich et al., "A streamlined process to phenotypically profile heterologous cDNAs in parallel using yeast cell-based assays", GENOME RES, 11(11), 2001, pp. 1899-1912
96. Nikaido, H
    Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
    
    H. Nikaido, "Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria", SEM CELL D, 12(3), 2001, pp. 215-223
97. Hrycyna, CA
    Molecular genetic analysis and biochemical characterization of mammalian P-glycoproteins involved in multidrug resistance
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
    
    C.A. Hrycyna, "Molecular genetic analysis and biochemical characterization of mammalian P-glycoproteins involved in multidrug resistance", SEM CELL D, 12(3), 2001, pp. 247-256
98. Bobadilla-del-Valle, M; Ponce-de-Leon, A; Axenas-Huertero, C; Vargas-Alarcon, G; Kato-Maeda, M; Small, PM; Couary, P; Ruiz-Palacios, GM; Sifuentes-Osornio, J
    rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism
    EMERGING INFECTIOUS DISEASES
    
    M. Bobadilla-del-Valle et al., "rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism", EM INFECT D, 7(6), 2001, pp. 1010-1013
99. McGowan, JE
    Economic impact of antimicrobial resistance
    EMERGING INFECTIOUS DISEASES
    
    J.E. McGowan, "Economic impact of antimicrobial resistance", EM INFECT D, 7(2), 2001, pp. 286-292
100. Abraham, EH; Shrivastav, B; Salikhova, AY; Sterling, KM; Johnston, N; Guidotti, G; Scala, S; Litman, T; Chan, KC; Arceci, RJ; Steiglitz, K; Herscher, L; Okunieff, P
     Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes
     BLOOD CELLS MOLECULES AND DISEASES
     
     E.H. Abraham et al., "Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes", BL CELL M D, 27(1), 2001, pp. 181-200